Quote:
Originally Posted by tytd
I've been intrigued by Birgitta's good response to low dose Thalidomide but you don't hear many of the experts recommending that here in the U.S. I know Revlimid is the supposed next-generation drug but is it really any better than low dose Thalidomide? I'm not sure how the costs compare either. You might ask Dr. Olnes about this.
|
Hi Tytd!
I will ask Dr. Olnes about this. If thalidomide is cheaper, one might wonder whether the profit motive is at play.
I fully expect, since Revlimid is not approved yet for non-5q, that I will be doing a clinical trial, even if that's my next choice. I think I'll do some searching on Thalidomide for MDS in clinical trials.gov.
Thanks much!
Greg
__________________
Greg, 59, dx MDS RCMD Int-1 03/10, 8+ & Dup1(q21q31). NIH Campath 11/2010. Non-responder. Tiny telomeres. TERT mutation. Danazol at NIH 12/11. TX independent 7/12. Pancreatitis 4/15. 15% blasts 4/16. DX RAEB-2. Beginning Vidaza to prep for MUD STC. Check out my blog at
www.greghankins.com